Chembio Shares Double on $28 Million COVID Diagnostic Test Order

112
10
Favorite

Chembio Shares Double on $28 Million COVID Diagnostic Test Order

The Street2021-07-21

Chembio will provide 20-minute nasal swab test to a company in Brazil. Shares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

112

Report

Comment（10）

NgKenny
·2021-07-22
Good
Reply
1
Report
ZomHui
·2021-07-22
Test dfghhjggk ghh
Reply
1
Report
Fold Replies
- ZomHui:
  Test
  2021-07-22
  Reply
  Report
Troytan
·2021-07-21
Wow what a great news
Reply
3
Report
Fold Replies
- JCBL:
  no revenue for us...too slow to react...
  2021-07-22
  Reply
  Report
- cweida:
  yup revenue coming!
  2021-07-22
  Reply
  Report
pompeepee
·2021-07-21
wow like
Reply
3
Report
flashsplash
·2021-07-21
Like please
Reply
3
Report
LZH93
·2021-07-21
Hello
Reply
2
Report
Maximus88
·2021-07-21
Up up up
Reply
4
Report
Alvintbs
·2021-07-21
.
Reply
1
Report
Winggg
·2021-07-21
Yes!
Reply
4
Report
Fold Replies
- mmcjb92:
  Good
  2021-07-21
  Reply
  Report
- WongKaiqi:
  ?
  2021-07-21
  Reply
  Report
- ecpm:
  [Strong]
  2021-07-21
  Reply
  Report
View more 1 comments
abp
·2021-07-21
Pls like and comment
Reply
3
Report
Fold Replies
- ldmmc:
  Good
  2021-07-21
  Reply
  Report
- KeithKoh:
  ok
  2021-07-21
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1139204971?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-21 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139204971","market":"us","top_or_hot":-1,"title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","media":"The Street","content":"<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Source Link</a>\n\n</div>\n","source":"lsy1610613172068","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CEMI","symbol_name":"Chembio Diagnostics","start_time":0,"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","article_id":"1139204971","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","pubTimestamp":1626873342,"sourceInfo":{"source_id":"lsy1610613172068","name":"The Street"},"weMediaInfo":null,"summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","collect":0,"end_time":0,"defaultTopTitle":"thestreet.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CEMI":"Chembio Diagnostics"},"translate_title":"Chembio在2800万美元的COVID诊断测试订单上股价翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CEMI":0.9},"content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":176547372,"gmtCreate":1626910003296,"gmtModify":1703480253034,"author":{"id":"3582778356971864","authorId":"3582778356971864","name":"NgKenny","avatar":"https://static.tigerbbs.com/4fdae3e0bdca8d3a33e7f9d619f0dc88","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176547372","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176216432,"gmtCreate":1626886916826,"gmtModify":1703480033176,"author":{"id":"3585045177553539","authorId":"3585045177553539","name":"ZomHui","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Test dfghhjggk ghh","listText":"Test dfghhjggk ghh","text":"Test dfghhjggk ghh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176216432","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5285898,"gmtCreate":1626886929275,"gmtModify":1663231282548,"authorId":3585045177553539,"author":{"id":3585045177553539,"authorId":3585045177553539,"name":"ZomHui","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176216432,"type":1,"supId":0,"prevId":0,"content":"Test","text":"Test","html":"Test"}],"langContent":"EN"},{"id":176631119,"gmtCreate":1626879019531,"gmtModify":1703479874919,"author":{"id":"3571482048865852","authorId":"3571482048865852","name":"Troytan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Wow what a great news","listText":"Wow what a great news","text":"Wow what a great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/176631119","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5288105,"gmtCreate":1626912689300,"gmtModify":1663231289667,"authorId":4087218051185710,"author":{"id":4087218051185710,"authorId":4087218051185710,"name":"JCBL","avatar":"https://static.tigerbbs.com/d52754657c86fcbf3892ea1fec33f39d","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176631119,"type":1,"supId":5285764,"prevId":0,"content":"no revenue for us...too slow to react...","text":"no revenue for us...too slow to react...","html":"no revenue for us...too slow to react..."},{"id":5285764,"gmtCreate":1626885417520,"gmtModify":1663231277550,"authorId":3575329601771279,"author":{"id":3575329601771279,"authorId":3575329601771279,"name":"cweida","avatar":"https://static.tigerbbs.com/b4cca1fdd58d7739662f062d01a402cf","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"80.84%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176631119,"type":1,"supId":0,"prevId":0,"content":"yup revenue coming!","text":"yup revenue coming!","html":"yup revenue coming!"}],"langContent":"EN"},{"id":176884606,"gmtCreate":1626876300205,"gmtModify":1703479767514,"author":{"id":"3577522329316309","authorId":"3577522329316309","name":"pompeepee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"wow like","listText":"wow like","text":"wow like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176884606","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176834506,"gmtCreate":1626875690705,"gmtModify":1703479739414,"author":{"id":"3559294375347885","authorId":"3559294375347885","name":"flashsplash","avatar":"https://static.tigerbbs.com/863a59e41a14a61b4df064012d89f382","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"Like please","listText":"Like please","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176834506","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176894397,"gmtCreate":1626875340919,"gmtModify":1703479724809,"author":{"id":"3561952980381559","authorId":"3561952980381559","name":"LZH93","avatar":"https://static.tigerbbs.com/dd274730798ffb61043997819bbeaa13","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"Hello","listText":"Hello","text":"Hello","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176894397","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176895910,"gmtCreate":1626875307930,"gmtModify":1703479722981,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176895910","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176893716,"gmtCreate":1626875203835,"gmtModify":1703479716651,"author":{"id":"3582535927405335","authorId":"3582535927405335","name":"Alvintbs","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176893716","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":176176782,"gmtCreate":1626874685346,"gmtModify":1703479691758,"author":{"id":"3567464873872520","authorId":"3567464873872520","name":"Winggg","avatar":"https://static.tigerbbs.com/bb11ae1d09ed1b2b766309f8126e45ed","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Yes!&nbsp;","listText":"Yes!&nbsp;","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/176176782","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5283570,"gmtCreate":1626875085937,"gmtModify":1663231271035,"authorId":4087294932864220,"author":{"id":4087294932864220,"authorId":4087294932864220,"name":"mmcjb92","avatar":"https://static.tigerbbs.com/cb0c911ee6f94cd0092cc258580fd6fa","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176176782,"type":1,"supId":5283500,"prevId":0,"content":"<u>Good</u>","text":"<u>Good</u>","html":"<u>Good</u>"},{"id":5283628,"gmtCreate":1626875327201,"gmtModify":1663231268164,"authorId":3581825335913090,"author":{"id":3581825335913090,"authorId":3581825335913090,"name":"WongKaiqi","avatar":"https://static.tigerbbs.com/1be2abd6ee4cc554089e3e3cb741fc3c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176176782,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"},{"id":5283500,"gmtCreate":1626874752059,"gmtModify":1663231267037,"authorId":3581565633996587,"author":{"id":3581565633996587,"authorId":3581565633996587,"name":"ecpm","avatar":"https://static.tigerbbs.com/dea1648fcfaa74eb7cd9caa81761cff4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176176782,"type":1,"supId":0,"prevId":0,"content":"[Strong]","text":"[Strong]","html":"[Strong]"},{"id":5283576,"gmtCreate":1626875105413,"gmtModify":1635224496853,"authorId":3573875235773606,"author":{"id":3573875235773606,"authorId":3573875235773606,"name":"JiaJun87","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.13","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176176782,"type":1,"supId":0,"prevId":0,"content":"[Miser][Miser][Miser]","text":"[Miser][Miser][Miser]","html":"[Miser][Miser][Miser]"}],"langContent":"EN"},{"id":176148319,"gmtCreate":1626874297831,"gmtModify":1703479674575,"author":{"id":"3581979721991802","authorId":"3581979721991802","name":"abp","avatar":"https://static.tigerbbs.com/f0c0424f61209387c56148e921c507f1","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/176148319","repostId":1139204971,"repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://www.laohu8.com/m/news/1139204971?lang=&edition=full","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5283542,"gmtCreate":1626874974991,"gmtModify":1663231269449,"authorId":3586831448052127,"author":{"id":3586831448052127,"authorId":3586831448052127,"name":"ldmmc","avatar":"https://static.tigerbbs.com/e473fe5b610503c2d96f2fc17fc52be3","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176148319,"type":1,"supId":5283460,"prevId":0,"content":"<u>Good</u>","text":"<u>Good</u>","html":"<u>Good</u>"},{"id":5283460,"gmtCreate":1626874621230,"gmtModify":1663231267131,"authorId":3585639778536044,"author":{"id":3585639778536044,"authorId":3585639778536044,"name":"KeithKoh","avatar":"https://static.tigerbbs.com/f6c2104097a8b30f0d1f6edc31597e68","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":176148319,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":112,"commentSize":10,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}